NIH-funded research Fellowship grant

Understanding how breast cancer cells use glutamine to spread to bones

Official title: Elucidating Glutamine Metabolism in Breast to Bone Metastasis

Funded at Vanderbilt University · NIH-10994964 · Data updated 2026-11-12

This study is looking at how breast cancer cells use a nutrient called glutamine to spread to bones and cause problems, with the hope of finding new ways to help patients avoid bone damage and improve treatment options.

More Metastasis research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startJuly 1, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$34,370
NIH project number1F31CA294618-01
Project IDNIH-10994964 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with metastatic breast cancer, particularly those experiencing bone metastasis.

Less likely to help

Patients with early-stage breast cancer or those without bone involvement may not benefit from this research.

What this research studies

This research investigates the role of glutamine metabolism in the spread of breast cancer to bones, a common and serious complication for many patients. The study focuses on how breast cancer cells that target bones utilize glutamine, a nutrient, to thrive and cause bone destruction. By using genetically modified mouse models, the researchers aim to uncover the mechanisms behind this process and explore potential therapeutic strategies to limit bone damage and tumor growth. The findings could lead to new treatments that target these metabolic pathways.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that reduce bone metastasis and improve outcomes for breast cancer patients.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach may lead to significant advancements.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Karno, Breelyn a — Vanderbilt University
  • Study coordinator: Karno, Breelyn a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.